Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Clinical research published in The Lancet Diabetes & Endocrinology confirmed that Retatrutides proportion of lean mass loss to weight loss was similar to other obesity treatments, providing reassurance that greater lean mass is not lost despite the overall increased weight loss
Administered via under-the-skin, or subcutaneous, injection, the therapy has been shown to reduce liver inflammation and scarring, known as fibrosis, in people with MASH and moderate to advanced liver fibrosis, but no cirrhosis, or irreversible liver fibrosis
Consulting a licensed healthcare provider is the best way to determine if it fits your health history and goals
Izraely S, Sagi-Assif O, Klein A, Meshel T, Tsarfaty G, Pasmanik-Chor M et al
US$ 23.23
US$ 23.93
US$ 22.72
US$ 26.04
